|
Indication |
To prevent infection with Corynebacterium
diphtheriae and Clostridium tetani. |
|
Proprietary Name |
DT (generic) |
|
Manufacturer |
sandofi pasteur |
|
Viability |
Inactivated |
|
Microorganism |
Corynebacterium diphtheriae
and Clostricium tetani |
|
Dose |
0.5 mL |
|
Route |
Intramuscular |
|
Dose form |
Suspension |
|
Appearance |
Turbid liquid, white, slightly gray |
|
Concentration (per 0.5 mL) |
Diphtheria, 6.7 Lf U
Tetanus, 5 LF U |
|
Preservatives |
Single dose - Thimerosal,
≤
0.3 mcg
Multi-dose - Thimerosal, 25 mcg mercury |
|
Adjuvant |
Aluminum potassium sulfate (≤
0.25 mg aluminum) |
|
Excipients |
Formaldehyde (residual-free), ≤0.02%
Variously formulated with glycine, sodium
phosphate, sodium acetate, hydrochloric acid
or sodium hydroxide |
|
Allergens |
None |
|
Media |
Modified Mueller and Miller
Pepton-based medium containing bovine
extract |
|
Packaging |
Single-dose (0.5 mL) vials; Multidose (5 mL)
vials |
|
Routine storage |
2 to 8°
C (36-46°
F)
Do Not Freeze |
|
updated July 2005 |